Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
Molecular Cell
|
February 9, 2021
Neuronal non-CG methylation is an essential target for MeCP2 function
Rebekah Tillotson, Justyna Cholewa-Waclaw, Kashyap Chhatbar, et al.
Molecular Oncology
|
March 30, 2013
Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancer
Jeffrey B Smerage, G Thomas Budd, Gerald V Doyle, et al.
Journal of Medicinal Chemistry
|
March 17, 2018
Discovery of an Orally Bioavailable Inhibitor of Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation
Jared T Hammill, Deepak Bhasin, Daniel C Scott, et al.
Scientific Reports
|
September 27, 2017
A Whole Blood Molecular Signature for Acute Myocardial Infarction
Evan D Muse, Eric R Kramer, Haiying Wang, et al.
Journal of Medicinal Chemistry
|
March 23, 2012
Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials
Yiqun Zhang, Julie A Clark, Michele C Connelly, et al.
Cancer Research
|
June 17, 2005
Global gene expression profiling of circulating tumor cells
Denis A Smirnov, Daniel R Zweitzig, Bradley W Foulk, et al.
Journal of Medicinal Chemistry
|
June 20, 2012
Lead optimization of antimalarial propafenone analogues
David Lowes, Anupam Pradhan, Lalitha V Iyer, et al.
Molecular Oncology
|
May 15, 2016
Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance
Costanza Paoletti, Jose M Larios, Maria C Muñiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2014
Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer
Costanza Paoletti, Maria C Muñiz, Dafydd G Thomas, et al.
Investigational New Drugs
|
March 17, 2017
Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study
Ravi Salgia, R Waide Weaver, Michael McCleod, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
Molecular Cell
|
February 9, 2021
Neuronal non-CG methylation is an essential target for MeCP2 function
Rebekah Tillotson, Justyna Cholewa-Waclaw, Kashyap Chhatbar, et al.
Molecular Oncology
|
March 30, 2013
Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancer
Jeffrey B Smerage, G Thomas Budd, Gerald V Doyle, et al.
Journal of Medicinal Chemistry
|
March 17, 2018
Discovery of an Orally Bioavailable Inhibitor of Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation
Jared T Hammill, Deepak Bhasin, Daniel C Scott, et al.
Scientific Reports
|
September 27, 2017
A Whole Blood Molecular Signature for Acute Myocardial Infarction
Evan D Muse, Eric R Kramer, Haiying Wang, et al.
Journal of Medicinal Chemistry
|
March 23, 2012
Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials
Yiqun Zhang, Julie A Clark, Michele C Connelly, et al.
Cancer Research
|
June 17, 2005
Global gene expression profiling of circulating tumor cells
Denis A Smirnov, Daniel R Zweitzig, Bradley W Foulk, et al.
Journal of Medicinal Chemistry
|
June 20, 2012
Lead optimization of antimalarial propafenone analogues
David Lowes, Anupam Pradhan, Lalitha V Iyer, et al.
Molecular Oncology
|
May 15, 2016
Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance
Costanza Paoletti, Jose M Larios, Maria C Muñiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2014
Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer
Costanza Paoletti, Maria C Muñiz, Dafydd G Thomas, et al.
Investigational New Drugs
|
March 17, 2017
Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study
Ravi Salgia, R Waide Weaver, Michael McCleod, et al.
Page
of 14